ConductScience.org, home

Paper6196462

Immunological treatment of multiple sclerosis.

Hughes RA. J Neurol, 1983. Cited by 10 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Immunological treatment of multiple sclerosis. Papers, record 6196462. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6196462

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Immunological treatment of multiple sclerosis.
PubMed
Journal
J Neurol
PubMed
Year
1983
PubMed
Publication types
Clinical Trial, Journal Article
PubMed
Citations, by iCite
10
iCite
Relative citation ratio, by iCite
0.49
iCite
Revised in PubMed
2019-08-29
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Hughes RAR A

Source PubMed

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Immunosuppressive AgentsMajor topic
Multiple SclerosisMajor topic
Adrenocorticotropic Hormone
Antibody Formation
Autoimmune Diseases
Clinical Trials as Topic
Humans
Immunization
Steroids

Source PubMed

References41

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
17,092,185Multiple sclerosis: trial of a synthetic polypeptide.Ann Neurol1982https://conductscience.org/library/papers/7092185PubMed
24,508,247Multiple sclerosis and autoimmune diseases.Aust N Z J Med1972https://conductscience.org/library/papers/4508247PubMed
36,248,818Immunosuppressive drugs in multiple sclerosis: pro and con.Neurology1980https://conductscience.org/library/papers/6248818PubMed
493,873Has myelin basic protein received a fair trial in the treatment of multiple sclerosis?Ann Neurol1979https://conductscience.org/library/papers/93873PubMed
56,164,763Short-term intensive cyclophosphamide treatment in multiple sclerosis. A retrospective controlled study.J Neurol1981https://conductscience.org/library/papers/6164763PubMed
66,196,463Past infectious events and disease evolution in multiple sclerosis.J Neurol1983https://conductscience.org/library/papers/6196463PubMed
76,171,035Intrathecal interferon reduces exacerbations of multiple sclerosis.Science1981https://conductscience.org/library/papers/6171035PubMed
86,157,007Azathioprine in multiple sclerosis--a 3 year controlled study of its effectiveness.J Neurol1980https://conductscience.org/library/papers/6157007PubMed
96,461,670The significance of abnormal immune responses in patients with multiple sclerosis.J Neuroimmunol1981https://conductscience.org/library/papers/6461670PubMed
106,188,564Immunological parameters in multiple sclerosis patients with special reference to the herpes virus group.Clin Exp Immunol1983https://conductscience.org/library/papers/6188564PubMed
116,294,517Intensive immunosuppression in progressive multiple sclerosis. A randomized, three-arm study of high-dose intravenous cyclophosphamide, plasma exchange, and ACTH.N Engl J Med1983https://conductscience.org/library/papers/6294517PubMed
1287,498Serum cortisol levels of multiple sclerosis patients during ACTH treatment.J Neurol1979https://conductscience.org/library/papers/87498PubMed
13213,744A review of systemic nonspecific immunosuppressive treatment of multiple sclerosis.Neurology1978https://conductscience.org/library/papers/213744PubMed
146,155,232Dysfunction of natural killer cells in multiple sclerosis: a possible pathogenetic factor.Clin Exp Immunol1980https://conductscience.org/library/papers/6155232PubMed
156,164,954Interferon responses of leukocytes in multiple sclerosis.Neurology1981https://conductscience.org/library/papers/6164954PubMed
16381,971The design of clinical studies to assess therapeutic efficacy in multiple sclerosis.Neurology1979https://conductscience.org/library/papers/381971PubMed
174,166,100Long-term treatment of multiple sclerosis with corticotrophin.Lancet1967https://conductscience.org/library/papers/4166100PubMed
186,157,011Effect of intensive immunosuppression on the course of chronic progressive multiple sclerosis.J Neurol1980https://conductscience.org/library/papers/6157011PubMed
1914,474,011Multiple sclerosis. Treatment of acute exacerbations with corticotrophin (A.C.T.H.).Lancet1961https://conductscience.org/library/papers/14474011PubMed
207,376,077Immunosuppression by hyperbaric oxygen.Surgery1980https://conductscience.org/library/papers/7376077PubMed

See all 41 references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 10 citations.

PMIDTitleJournalYearIn PapersSource
3,997,466Lymphocytoplasmapheresis in multiple sclerosis: preliminary laboratory findings.Ital J Neurol Sci1985https://conductscience.org/library/papers/3997466PubMed
3,009,722Immunological treatment of multiple sclerosis. II.J Neurol1986https://conductscience.org/library/papers/3009722PubMed
2,081,68624-month follow-up of multiple sclerosis patients treated with cyclophosphamide.Ital J Neurol Sci1990https://conductscience.org/library/papers/2081686PubMed

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
POMC5,443PubTator's text mininghttps://conductscience.org/library/genes/5443

Source NCBI Gene

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/6196462

GET https://conductscience.org/api/papers/v1/6196462/references?page=2